Switch View
© BusinessWire
16.10.2025
ISIN: US1570851014
Cerus Corp
CERS
LISTED
NASDAQ
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025
News Preview
Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Company’s financial results and provide a general business...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US2546041011
Disc Medicine Inc
IRON
LISTED
NASDAQ
Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)
News Preview
WATERTOWN, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it received a Commissioner’s National Priority Voucher (CN...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
News Preview
SAN FRANCISCO, Oct. 16, 2025 /PRNewswire/ -- A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake (NASDAQ: MLTX) announced disastrous Phase 3 trial results for its only product candidate (sonelokimab, or "SLK"), its highly...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
16.10.2025
ISIN: US90184D1000
Twist Bioscience Corp
TWST
LISTED
NASDAQ
Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm
News Preview
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to shareholders. ...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
16.10.2025
ISIN: US52886X1072
Lexeo Therapeutics Inc
LXEO
LISTED
NASDAQ
Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
News Preview
Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US3795772082
Globus Medical Inc
GMED
LISTED
NYSE
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
News Preview
AUDUBON, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2025 after the market close on Thursday, November 6, 2025. A copy of the release will be available on the Globus Medical website at www.invest...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US4500561067
iRhythm Technologies Inc
IRTC
LISTED
NASDAQ
iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025
News Preview
iRhythm Technologies to Report Third Quarter 2025
Financial Results on October 30, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US8793691069
Teleflex Inc
TFX
LISTED
NYSE
Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
News Preview
WAYNE, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 6, 2025....
Themefolio
Profiler
Peergroup
© Newsfile
16.10.2025
ISIN: CA01559R4008
Algernon Pharmaceuticals Inc.
AGN
LISTED
CSE
CSE Bulletin: Name Change - Algernon Pharmaceuticals Inc. (AGN)
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 16 octobre/October 2025) - Algernon Pharmaceuticals Inc. has announced a name change to Algernon Health Inc. Shares will begin trading under the new name and with a new CUSIP number on October 20, 2025. The symbol will remain the same. Disclosure documents are available...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US53228F1012
LifeStance Health Group Inc
LFST
LISTED
NASDAQ
LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025
News Preview
SCOTTSDALE, Ariz., Oct. 16, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its third quarter 2025 earnings release before the market opens on Thursday, November 6, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US44975P1030
I-Mab
IMAB
LISTED
NASDAQ
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences
News Preview
ROCKVILLE, Md., Oct. 16, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (I-Mab or the Company), a global biotechnology platform company committed to accelerating access to innovative medicines for patients worldwide, announced its new business model, focused on its global capabilities built to accelerate access to innovative medicines and to enabl...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US04317A1079
Artiva Biotherapeutics, Inc.
ARTV
LISTED
NASDAQ
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update
News Preview
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
16.10.2025
ISIN: US81578P1066
Seer Inc
SEER
LISTED
NASDAQ
Seer to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the third quarter 2025 on Thursday, November 6, 2025. Company management will be webcasting a conference call beginning at 1:30 p.m. Pac...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Securities Fraud Investigation Into aTyr Pharma Inc. (ATYR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of aTyr Pharma Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON ATYR PHARMA...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of aTyr Pharma Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ATYR PHARMA INC. (ATYR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PUR...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US2560861096
DocGo Inc
DCGO
LISTED
NASDAQ
KILL DocGo Signs Deal to Launch Care Gap Closure Program in New Mexico With National Insurance Provider
News Preview
DocGo, Inc. requests that their press release NewsItemId: 20251016393304 “DocGo Signs Deal to Launch Care Gap Closure Program in New Mexico With National Insurance Provider” be killed.
The release was issued in error by DocGo, Inc....
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US2560861096
DocGo Inc
DCGO
LISTED
NASDAQ
DocGo Signs Deal to Launch Care Gap Closure Program in New Mexico With National Insurance Provider
News Preview
DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled medical transportation and mobile health services, today announced the planned launch of care gap closure services in New Mexico to enhance health care access for 10,000 Turquoise Care enrollees/patients/members. The program – an expansion of the Company...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Rosen Law Firm Urges MoonLake Immunotherapeutics (NASDAQ: MLTX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of MoonLake Immunotherapeutics (NASDAQ: MLTX) common stock between March 10, 2024 and September 29, 2025, both dates inclusive (the “Class Period”). MoonLake is a clinical-stage biotechnology company....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: FR0000121667
EssilorLuxottica SA
EL
LISTED
EURONEXT
EssilorLuxottica: Q3/9M 2025 Revenue - Revenue up 11.7% in the third quarter, best quarterly performance ever for the Group
News Preview
Revenue up 11.7% in the third quarter...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly confirms date and conference call for third-quarter 2025 financial results announcement
News Preview
INDIANAPOLIS, Oct. 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2025 financial results on October 30, 2025. Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial performance. ...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
OpenEvidence and Veeva Announce Open Vista Partnership
News Preview
PLEASANTON, Calif. and MIAMI, Oct. 16, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) and OpenEvidence today announced the formation of a long-term partnership to jointly create and market Open Vista. Open Vista will use AI to increase patient access to clinical trials, accelerate drug discovery through better u...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
OpenEvidence and Veeva Announce Open Vista Partnership
News Preview
PLEASANTON, Calif. and MIAMI, Oct. 16, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) and OpenEvidence today announced the formation of a long-term partnership to jointly create and market Open Vista. Open Vista will use AI to increase patient access to clinical trials, accelerate drug discovery through better u...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.10.2025
ISIN: US74265M2052
Pro-Dex Inc.
PDEX
LISTED
NASDAQ
Pro-Dex, Inc. Announces Clarification Related to Trading Symbol
News Preview
IRVINE, CA / ACCESS Newswire / October 16, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) is issuing this press release in an effort to help avoid any confusion in the marketplace between the common stock of Pro-Dex, Inc., which trades on the Nasdaq Capital Market under the symbol PDEX, and Polkadex, which to Pro-Dex, Inc.'s understanding trades on certain c...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: FR0000031577
Virbac SA
VIRP
LISTED
EURONEXT
VIRBAC Announces Third Quarter 2025 Sales
News Preview
Press release on October 16, 2025, after market close at 5:45 p.m. CEST...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: AU0000165375
Clarity Pharmaceuticals Ltd
CU6
LISTED
ASX
Clarity signs copper-67 Supply Agreement with Nusano
News Preview
SYDNEY, Oct. 16, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a Supply Agreement for...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
The Gross Law Firm Notifies Shareholders of Nutex Health Inc.(NUTX) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
Shareholders who purc...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA LAWSUIT ALERT: The Gross Law Firm Notifies Savara Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
News Preview
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
The Gross Law Firm Reminds Lantheus Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 10, 2025 - LNTH
News Preview
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders wh...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
The Gross Law Firm Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025 - CYTK
News Preview
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK).
Shareholders...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before October 25, 2025 to Discuss Your Rights - LFMD
News Preview
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Class Action Filed Against Semler Scientific, Inc. (SMLR) Seeking Recovery for Investors - Contact The Gross Law Firm
News Preview
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR).
Shareholders wh...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
The Gross Law Firm Reminds aTyr Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 8, 2025 - ATYR
News Preview
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of aTyr Pharma, Inc. (NASDAQ: ATYR).
Shareholders who purc...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US05370A1088
Avidity Biosciences Inc
RNA
LISTED
NASDAQ
Avidity Biosciences to Participate in Upcoming Investor Conference
News Preview
SAN DIEGO, Oct. 16, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that Avidity management will participate in a panel discussion at the following...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US71535D1063
Personalis, Inc.
PSNL
LISTED
NASDAQ
Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing
News Preview
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced new data from an AstraZeneca phase 3 clinical trial in lung cancer (LAURA). The findings demonstrate that Personalis’ highly sensitive molecular residual disease (MRD) test, NeXT Personal®, is a useful tool in assessing the maintenance treatment respon...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US03073E1055
Cencora Inc
COR
LISTED
NYSE
IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes
News Preview
IntrinsiQ® Specialty Solutions (IntrinsiQ), a leader in data analytic solutions, and part of Cencora, can now offer expanded data and insights for oncology, retina and other therapeutic areas. As part of this expansion, IntrinsiQ is now also offering oncology biomarker data, enabling physicians to transition from a generalized treatment approach t...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US6821431029
Omeros Corp
OMER
LISTED
NASDAQ
Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group
News Preview
Omeros Corporation (Nasdaq: OMER) today announced the publication of a peer-reviewed manuscript in Blood Advances, a journal of the American Society of Hematology, detailing survival outcomes in adult patients with life-threatening transplant-associated thrombotic microangiopathy (TA-TMA) treated with narsoplimab across both the pivotal clinical t...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a multi-year collaboration with Whitehawk Therapeutics, Inc. (NASDAQ: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjuga...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US3847471014
Grail, Inc.
GRAL
LISTED
NASDAQ
Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-Cancer Early Detection Test to Asia
News Preview
Samsung C&T and Samsung Electronics Will Make an Equity Investment of $110 Million Into GRAIL, Subject to Closing Conditions
Samsung C&T Will Drive Commercialization of Galleri in South Korea W...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: KYG8807B1068
Theravance Biopharma Inc
TBPH
LISTED
NASDAQ
Theravance Biopharma Launches Disease Education Campaign to Advance Scientific Understanding of Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy
News Preview
Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced the launch of “Power in the Periphery,” a new disease education campaign for healthcare professionals (HCPs) to raise awareness and deepen scientific understanding of the pathophysiology underlying neurogenic orthostatic hypotension (nOH) associated with Multiple System Atrophy (MSA). The i...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
TECVAYLI® plus DARZALEX FASPRO® combination regimen significantly improves progression-free survival and overall survival versus standard of care
News Preview
First Phase 3 study (MajesTEC-3) of an investigational combination to show benefit in PFS and OS in relapsed/refractory multiple myeloma as early as second line...
Themefolio
Profiler
Peergroup
© Newsfile
16.10.2025
ISIN: CA71716H1082
PharmaTher Holdings Ltd.
PHRM
LISTED
CSE
PharmaTher Advances Phase 3 FDA Package for Ketamine in LID-Parkinson's Disease
News Preview
Company preparing FDA meeting package to align on a single, well-controlled Phase 3 study under 505(b)(2); Pharma partner discussions ongoingToronto, Ontario--(Newsfile Corp. - October 16, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty life sciences company focused on unlocking the...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US68218J1034
OmniAb Inc
OABI
LISTED
NASDAQ
OmniAb to Participate in Three Investor Conferences in November
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three investor conferences during the month of November.
2025 Truist Securities BioPharma Symposium, November 6 at the Lotte New York Palace Hotel. Matt Foehr, Chief Executive Officer, will participate in one-on-one meetings with investors on Thursday, November...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US8835561023
Thermo Fisher Scientific Inc
TMO
LISTED
NYSE
Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI
News Preview
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through the use of artificial intelligence (AI) with OpenAI. This collaboration will help to improve the speed and success of drug development, enabling customers to get medicines...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US02043Q1076
Alnylam Pharmaceuticals Inc
ALNY
LISTED
NASDAQ
Alnylam to Webcast Conference Call Discussing Third Quarter 2025 Financial Results
News Preview
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the third quarter ending September 30, 2025 on Thursday, October 30, 2025, before the U.S. financial markets open.
Management will provide an update on the Company and discuss third quarter 2025 results a...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Natera Named to Fast Company’s Next Big Things in Tech List
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it has been named to Fast Company’s 2025 Next Big Things in Tech list. Honored for its Signatera personalized molecular residual disease (MRD) test, Natera was one of five companies recognized in the health and medicine category.
This annua...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Ionis to hold third quarter 2025 financial results webcast
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, October 29th at 11:30 a.m. Eastern Time to discuss its third quarter 2025 financial results and progress on key programs.
The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be availabl...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US4576693075
Insmed Inc
INSM
LISTED
NASDAQ
Insmed to Present Multiple Analyses from Phase 3 ASPEN Study at the American College of Chest Physicians Annual Meeting 2025
News Preview
—Data on Structural Lung Changes from a High-Resolution CT Substudy to be Presented as Late-Breaker—
—Additional Analyses Will Highlight Efficacy, Symptom Reduction, and Biomarker Suppression in Patients with Non-Cystic Fibrosis Bronchiectasis—...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US31447E1055
Femasys Inc
FEMY
LISTED
NASDAQ
Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo
News Preview
Will Showcase Latest Fertility Solutions Will Showcase Latest Fertility Solutions...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US3596641098
Fulgent Genetics Inc
FLGT
LISTED
NASDAQ
Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025
News Preview
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its third quarter 2025 financial results before the market opens on Friday, November 7, 2025. Management will host a confere...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US74587B1017
Pulse Biosciences Inc
PLSE
LISTED
NASDAQ
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced that the Compensation Committee of its Board of Directors has granted equity awards to three new employees as equity inducement awards outside of the Co...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD Looks Ahead to the Next Era of Manufacturing Excellence in Broken Bow, NE and Celebrates 65 Years of Innovation in the Region
News Preview
BROKEN BOW, Neb., Oct. 16, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, proudly commemorates 65 years of manufacturing excellence at its Broken Bow, Nebraska facility—a cornerstone of BD's extensive U.S. manufacturing network....
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck Announces Phase 3 KEYNOTE-B96 Trial Met Secondary Endpoint of Overall Survival (OS) in All Comers Population of Patients With Platinum-Resistant Recurrent Ovarian Cancer
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-B96 trial, also known as ENGOT-ov65, met its secondary endpoint of overall survival (OS) for the treatment of patients with platinum-resistant recurrent ovarian cancer in all comers. The trial studied KEYTRUDA® (pembrolizumab), Merck’s...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US59503A2042
Microbot Medical Inc.
MBOT
LISTED
NASDAQ
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
News Preview
First U.S. Based Medical Meeting Presence Post-FDA Clearance Will Allow the Company to Commercially Engage Future Potential Users of the LIBERTY® System...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: CA98420N1050
Xenon Pharmaceuticals Inc.
XENE
LISTED
NASDAQ
Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer
News Preview
Mr. Kelly is a proven strategic CFO with significant financial, operational and commercialization leadership experience Mr. Kelly is a proven strategic CFO with significant financial, operational and commercialization leadership experience...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US6907321029
Owens & Minor Inc
OMI
LISTED
NYSE
Owens & Minor Announces Date and Time Change of Third Quarter 2025 Financial Results and Conference Call
News Preview
Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2025 on Thursday, October 30, 2025, after trading ends on the New York Stock Exchange.
The Company will host a conference call for investors and analysts at 5:00 p.m. EDT on the same day. Participants may access the call via the toll-free dial-in numb...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US1374041093
Candel Therapeutics, Inc.
CADL
LISTED
NASDAQ
Candel Therapeutics Appoints Leading Systems Immunology Expert Bali Pulendran, Ph.D., to Research Advisory Board
News Preview
NEEDHAM, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the appointment of Bali Pulendran, Ph.D. to Candel’s Research Advisory Board (RAB)...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US67080T1088
Nuvectis Pharma Inc
NVCT
LISTED
NASDAQ
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
News Preview
Fort Lee, NJ, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced upcoming poster presentations for NXP900 at the 2025 AACR-NCI-EORTC...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.10.2025
ISIN: AU000000ANN9
Ansell Ltd
ANN
LISTED
ASX
Ansell Launches Hyflex(TM) Precision Comfort Series with Aerofit(TM) Technology
News Preview
ISELIN, NEW JERSEY / ACCESS Newswire / October 16, 2025 / Ansell Limited (ASX:ANN), a global leader in protection solutions, announced the launch of HyFlex™ Precision Comfort Series with AEROFIT™ Technology, a new line of industrial gloves designed to boost precision and productivity of workers by providing a true second-skin fit for ex...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US12529R1077
C4 Therapeutics Inc
CCCC
LISTED
NASDAQ
C4 Therapeutics Announces Pricing of $125 Million Underwritten Offering
News Preview
$125 Million in Upfront Proceeds Expected to Fund Next Phase of Cemsidomide Multiple Myeloma Development Including Registrational Phase 2 Trial in Combination with Dexamethasone and Phase 1b Trial in Combination with Elranatamab...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
WATERTOWN, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outsid...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
